{"schema_version":"secwatch.filing_event.v1","accession":"0001650664-23-000034","form_type":"8-K","ticker":"EDIT","cik":"0001650664","company_name":"Editas Medicine, Inc.","filed_at":"2023-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.940249+00:00","generated_at":"2026-06-07T14:55:00.634856+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Editas reports EDIT-301 (reni-cel) data: all 11 SCD patients free of vaso-occlusive events","bullets":["All 11 SCD patients in RUBY trial free of vaso-occlusive events post reni-cel; 6 with >=5 months follow-up achieved normal Hb and >40% fetal Hb.","6 TDT patients in EdiTHAL trial showed early robust total hemoglobin rise above 9 g/dL transfusion independence threshold.","Reni-cel well-tolerated in all 17 patients; safety profile consistent with myeloablative conditioning; no SAEs related to reni-cel reported.","Data presented at ASH and company webinar; additional dosing and further updates expected mid-2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001650664-23-000034","json":"https://secwatch.observer/filing/0001650664-23-000034.json","markdown":"https://secwatch.observer/filing/0001650664-23-000034.md","text":"https://secwatch.observer/filing/0001650664-23-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650664/000165066423000034/0001650664-23-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650664/000165066423000034/edit-20231211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:55:00.634856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}